Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3066)	8/9/2010 1:57:46 PM
From: Jibacoa	Respond to of 3722

NWBO reported last week that long-Term Follow-Up of DCVax treated brain Ca patients showed that 33% reached 4-Yr. Survival and 27% reached or exceeded 6-Yr. survival. But the stock in spite of its recent spikes, has continued to drift down below the $1 level.<g> bigcharts.marketwatch.com There was a recent positive article on S.A. seekingalpha.com The ACTAY is $4.40 But the insiders that reportedly hold > 40% have been consistent sellers.<g> finance.yahoo.com And with its large LTD and poor cash position NWBO will need further financing in order to keep going.<g> However, if it can come with the $$ and some good news, the stock has plenty of room to run.<g> bigcharts.marketwatch.com Bernard